Ohcanbohtosat - A. Penfornis

Aiddostahte ozu
  1. 1
    Adherence to antihyperglycemic medications and glucagon-like peptide 1-receptor agonists in type 2 diabetes: clinical consequences and strategies for improvement

    Adherence to antihyperglycemic medications and glucagon-like peptide 1-receptor agonists in type 2 diabetes: clinical consequences and strategies for improvement Dahkki Francesco Giorgino, A. Penfornis, V. Pechtner, R. Gentilella, Antonella Corcos

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p?DDD) levels on the treatment of patients with adrenocortical carcinoma

    Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p?DDD) levels on the treatment of patients with adrenocortical carcinoma Dahkki Eric Baudin, Gabriella Pellegriti, M. Bonnay, A. Penfornis, A. Laplanche, Gilles Vassal, Martin Schlumberger

    Almmustuhtton 2001
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Impact of Intensive Glycemic Treatment on Diabetes Complications—A Systematic Review

    Impact of Intensive Glycemic Treatment on Diabetes Complications—A Systematic Review Dahkki Juliana Poonoosamy, Philippe Lopes, Priscille Huret, Randa Dardari, A. Penfornis, Claire Thomas, Dured Dardari

    Almmustuhtton 2023
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Diabeloop DBLG1 Closed-Loop System Enables Patients With Type 1 Diabetes to Significantly Improve Their Glycemic Control in Real-Life Situations Without Serious Adverse Events: 6-Month Follow-up

    Diabeloop DBLG1 Closed-Loop System Enables Patients With Type 1 Diabetes to Significantly Improve Their Glycemic Control in Real-Life Situations Without Serious Adverse Events: 6-M... Dahkki Coralie Amadou, Sylvia Franc, Pierre‐Yves Benhamou, Sandrine Lablanche, Erik Huneker, G. Charpentier, A. Penfornis

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening

    Detection of silent myocardial ischemia in asymptomatic patients with diabetes: results of a randomized trial and meta-analysis assessing the effectiveness of systematic screening Dahkki Michel Lièvre, Philippe Moulin, Charles Thivolet, Michel Rodier, Vincent Rigalleau, A. Penfornis, A. Pradignac, Michel Ovize

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Medication Adherence in Type 2 Diabetes: The ENTRED Study 2007, a French Population-Based Study

    Medication Adherence in Type 2 Diabetes: The ENTRED Study 2007, a French Population-Based Study Dahkki Michel Tiv, Jean‐François Viel, Frédéric Mauny, É. Eschwège, Alain Weill, Cécile Fournier, A. Fagot‐Campagna, A. Penfornis

    Almmustuhtton 2012
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Expression of Major Histocompatibility Complex Class I Chain–Related Molecule A, NKG2D, and Transforming Growth Factor–β in the Liver of Humans with Alveolar Echinococcosis: New Actors in the Tolerance to Parasites?

    Expression of Major Histocompatibility Complex Class I Chain–Related Molecule A, NKG2D, and Transforming Growth Factor–β in the Liver of Humans with Alveolar Echinococcosis: New Ac... Dahkki Shao‐Ling Zhang, Sophie Hüe, D. Séné, A. Penfornis, Solange Bresson‐Hadni, B Kantelip, Sophie Caillat‐Zucman, Dominique A. Vuitton

    Almmustuhtton 2008
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Sequential Occurrence of Thyroid Autoantibodies and Graves’ Disease after Immune Restoration in Severely Immunocompromised Human Immunodeficiency Virus-1-Infected Patients

    Sequential Occurrence of Thyroid Autoantibodies and Graves’ Disease after Immune Restoration in Severely Immunocompromised Human Immunodeficiency Virus-1-Infected Patients Dahkki V. Jubault, A. Penfornis, F. Schillo, Bruno Hoën, M Izembart, José Timsit, Michel D. Kazatchkine, Jacques Gilquin, Jean‐Paul Viard

    Almmustuhtton 2000
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Accuracy of a New Patch Pump Based on a Microelectromechanical System (MEMS) Compared to Other Commercially Available Insulin Pumps

    Accuracy of a New Patch Pump Based on a Microelectromechanical System (MEMS) Compared to Other Commercially Available Insulin Pumps Dahkki Sophie Borot, Sylvia Franc, Justine Cristante, A. Penfornis, Pierre‐Yves Benhamou, Bruno Guerci, H. Hanaire, Éric Renard, Yves Reznik, Chantal Simon, Guillaume Charpentier

    Almmustuhtton 2014
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    Hospital stays and costs of telemedical monitoring versus standard follow-up for diabetic foot ulcer: an open-label randomised controlled study

    Hospital stays and costs of telemedical monitoring versus standard follow-up for diabetic foot ulcer: an open-label randomised controlled study Dahkki Dured Dardari, Sylvia Franc, G. Charpentier, L. Orlando, Elise Bobony, Marie Bouly, I. Xhaard, Zohra Amrous, Khadijatou Ly Sall, B. Detournay, A. Penfornis

    Almmustuhtton 2023
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    IL-6 Promoter Polymorphism −174 Is Associated with New-Onset Diabetes after Transplantation

    IL-6 Promoter Polymorphism −174 Is Associated with New-Onset Diabetes after Transplantation Dahkki Jamal Bamoulid, CeCombining Acute Accentcile Courivaud, Marina Deschamps, P Mercier, Christophe Ferrand, A. Penfornis, Pierre Tiberghien, Jean‐Marc Chalopin, Philippe Saas, Didier Ducloux

    Almmustuhtton 2006
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    Human islet transplantation network for the treatment of Type I diabetes: first data from the Swiss-French GRAGIL consortium (1999-2000)

    Human islet transplantation network for the treatment of Type I diabetes: first data from the Swiss-French GRAGIL consortium (1999-2000) Dahkki Christian Toso, Laurence Kessler, A. Penfornis, François Bayle, Charles Thivolet, P. Morel, Frédéric Ris, P.Y. Benhamou, José Oberholzer, Cyrille Colin, L. Badet, X. Martin

    Almmustuhtton 2001
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    Insulin‐based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the <scp>DIABRASPORT</scp> randomized study

    Insulin‐based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the <scp>DIABRASPORT</scp> randomized study Dahkki Sylvia Franc, A. Daoudi, A. Pochat, M. Petit, Caroline Randazzo, C. Petit, Martine Duclos, A. Penfornis, Eric Pussard, D. Not, Elsa Heyman, François Koukoui, Chantal Simon, G. Charpentier

    Almmustuhtton 2015
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    The Diabeo Software Enabling Individualized Insulin Dose Adjustments Combined With Telemedicine Support Improves HbA1c in Poorly Controlled Type 1 Diabetic Patients

    The Diabeo Software Enabling Individualized Insulin Dose Adjustments Combined With Telemedicine Support Improves HbA1c in Poorly Controlled Type 1 Diabetic Patients Dahkki G. Charpentier, Pierre‐Yves Benhamou, Dured Dardari, Annie Clergeot, Sylvia Franc, P Schaepelynck-Bélicar, Bogdan Catargi, V. Melki, Lucy Chaillous, Anne Farret, Jean‐Luc Bosson, A. Penfornis

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    An Effective Intervention for Diabetic Lipohypertrophy: Results of a Randomized, Controlled, Prospective Multicenter Study in France

    An Effective Intervention for Diabetic Lipohypertrophy: Results of a Randomized, Controlled, Prospective Multicenter Study in France Dahkki Catherine Campinos, Jean‐Pierre Le Floch, Catherine Petit, A. Penfornis, Patrice Winiszewski, L. Bordier, Marie L. Lepage, C. Fermon, Jacques Louis, Catherine Almain, Didier Morel, Laurence Hirsch, Kenneth Strauss

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    Prise de position de la Société Francophone du Diabète (SFD) sur la prise en charge médicamenteuse de l’hyperglycémie du patient diabétique de type 2

    Prise de position de la Société Francophone du Diabète (SFD) sur la prise en charge médicamenteuse de l’hyperglycémie du patient diabétique de type 2 Dahkki Patrice Darmon, B. Bauduceau, L. Bordier, J. Bringer, G. Chabrier, B Charbonnel, B. Detournay, P. Fontaine, André Grimaldi, Pierre Gourdy, Bruno Guerci, A. Penfornis, Jean‐Pierre Riveline, André Scheen

    Almmustuhtton 2017
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    Pancreatic involvement in von Hippel–Lindau disease

    Pancreatic involvement in von Hippel–Lindau disease Dahkki Pascal Hammel, Valérie Vilgrain, Benoı̂t Terris, A. Penfornis, Alain Sauvanet, Jean-Michel Corréas, Dominique Chauveau, Axel Balian, Catherine Beigelman‐Aubry, Dermot O’Toole, P Bernadès, Philippe Ruszniewski, Richard J. Kahnoski

    Almmustuhtton 2000
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    Expectations and Strategies Regarding Islet Transplantation: Metabolic Data From the GRAGIL 2 Trial

    Expectations and Strategies Regarding Islet Transplantation: Metabolic Data From the GRAGIL 2 Trial Dahkki Lionel Badet, Pierre‐Yves Benhamou, Anne Wojtusciszyn, Reto M. Baertschiger, Laure Guittard, Laurence Kessler, A. Penfornis, Charles Thivolet, Éric Renard, Domenico Bosco, Philippe Morel, Emmanuel Morélon, François Bayle, Cyrille Colin, Thierry Berney

    Almmustuhtton 2007
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    Effectiveness and tolerability of second‐line therapy with vildagliptin vs. other oral agents in type 2 diabetes: A real‐life worldwide observational study (<scp>EDGE</scp>)

    Effectiveness and tolerability of second‐line therapy with vildagliptin vs. other oral agents in type 2 diabetes: A real‐life worldwide observational study (<scp>EDGE</scp>) Dahkki Chantal Mathieu, Anthony Barnett, Helmut Brath, Ignacio Conget, José J Castro, Rüdiger Göke, Ezequiel Rodríguez, Peter M. Nilsson, Emmanouil Pagkalos, A. Penfornis, Nicolaas C. Schaper, SUBHASH KUMAR WANGNOO, Wolfgang Kothny, Giovanni Bader

    Almmustuhtton 2013
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    Five-Year Metabolic, Functional, and Safety Results of Patients With Type 1 Diabetes Transplanted With Allogenic Islets Within the Swiss-French GRAGIL Network

    Five-Year Metabolic, Functional, and Safety Results of Patients With Type 1 Diabetes Transplanted With Allogenic Islets Within the Swiss-French GRAGIL Network Dahkki Sandrine Lablanche, Sophie Borot, Anne Wojtusciszyn, François Bayle, Rachel Tétaz, Lionel Badet, Charles Thivolet, Emmanuel Morélon, Luc Frimat, A. Penfornis, L. Kessler, Coralie Brault, Cyrille Colin, Igor Tauveron, Domenico Bosco, Thierry Berney, Pierre‐Yves Benhamou

    Almmustuhtton 2015
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: